Trinity Biotech Stock (NASDAQ: TRIB) stock price, news, charts, stock research, profile.
Open | $1.660 |
Close | $1.802 |
Volume / Avg. | 13.885K / 21.648K |
Day Range | 1.660 - 1.802 |
52 Wk Range | 1.680 - 5.500 |
Market Cap | $12.685M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 40 |
Short Interest | 0.03% |
Days to Cover | 1 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Trinity Biotech (NASDAQ: TRIB) through any online brokerage.
Other companies in Trinity Biotech’s space includes: Predictive Oncology (NASDAQ:POAI), Nexalin Technology (NASDAQ:NXL), Venus Concept (NASDAQ:VERO), Talis Biomedical (NASDAQ:TLIS) and QT Imaging Holdings (NASDAQ:QTI).
The latest price target for Trinity Biotech (NASDAQ: TRIB) was reported by Stephens & Co. on Wednesday, October 5, 2016. The analyst firm set a price target for 0.00 expecting TRIB to fall to within 12 months (a possible -100.00% downside). 0 analyst firms have reported ratings in the last year.
The stock price for Trinity Biotech (NASDAQ: TRIB) is $1.66 last updated May 3, 2024 at 8:38 AM EDT.
A quarterly cash dividend of $0.22 per share of Class A Common Stock. The quarterly cash dividend was payable on July 1, 2015 to stockholders of record on June 5, 2015.
Trinity Biotech’s Q1 earnings are confirmed for Friday, July 5, 2024.
There is no upcoming split for Trinity Biotech.
Trinity Biotech is in the Health Care sector and Health Care Equipment & Supplies industry. They are listed on the NASDAQ.